Peripheral Embolic Protection Devices – Medical Devices Pipeline Assessment, 2020

Embolic Protection Devices (EPDs) are used to capture and remove plaque debris that is dislodged during interventional procedures. GlobalData's Medical Devices sector report, “Peripheral Embolic Protection Devices – Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Peripheral Embolic Protection Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Peripheral Embolic Protection Devices Pipeline Assessment report provides key information and data related to:

Extensive coverage of the Peripheral Embolic Protection Devices under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Peripheral Embolic Protection Devices pipeline products.

Review of Recent Developments in the segment / industry

The Peripheral Embolic Protection Devices Pipeline Assessment report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Glaucoma Drainage Device sunder development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

The major companies covered in the “Peripheral Embolic Protection Devices- Medical Devices Pipeline Assessment, 2020” report:

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025

• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports

• 64,000+ medical equipment company profiles

• 5,600+ company profiles of medical equipment manufacturers in China and India

• 2,200+ company profiles of medical equipment manufacturers in Japan

• 1,200+ companies’ revenue splits and market shares

• 1,600+ quarterly and annual medical equipment company financials

• 850+ medical equipment company SWOTs

• 28,000+ pipeline product profiles

• 56,400+ marketed product profiles

• 47,000+ clinical trials

• 41,500+ trial investigators

• 7,000+ reports on companies with products in development

• 44,000+ deals in the medical equipment industry

• 1,100+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

• 431,000+ Themes Content Items

• 600+ Influencers

• 1,900+ Analysts & Researchers

• 0.5m+ Community Members

• 141,000+ Macroeconomic Indicators

• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Peripheral Embolic Protection Devices under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Peripheral Embolic Protection Devices and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of Peripheral Embolic Protection Devices under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies mentioned

Abbott Vascular Inc

AorticLab Sarl

Artio Medical

Avantec Vascular Corp

Capture Vascular Inc

Cardio-Flow Ltd.

Cardiovascular Systems Inc

Emboline, Inc.

Filterlex Medical Ltd

Innovative Cardiovascular Solutions, LLC

Innovia LLC

Javelin Medical Ltd

Keystone Heart Ltd

Marblehead Medical LLC

Medtronic Plc

MIV Therapeutics Inc

Neurosonix Ltd.

Protembis GmbH

University of Minnesota

University of Toledo

Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Peripheral Embolic Protection Devices Overview 6

3 Products under Development 7

3.1 Peripheral Embolic Protection Devices – Pipeline Products by Stage of Development 7

3.2 Peripheral Embolic Protection Devices – Pipeline Products by Segment 8

3.3 Peripheral Embolic Protection Devices – Pipeline Products by Territory 9

3.4 Peripheral Embolic Protection Devices – Pipeline Products by Regulatory Path 10

3.5 Peripheral Embolic Protection Devices – Pipeline Products by Estimated Approval Date 11

3.6 Peripheral Embolic Protection Devices – Ongoing Clinical Trials 12

4 Peripheral Embolic Protection Devices – Pipeline Products under Development by Companies 13

4.1 Peripheral Embolic Protection Devices Companies – Pipeline Products by Stage of Development 13

4.2 Peripheral Embolic Protection Devices – Pipeline Products by Stage of Development 14

5 Peripheral Embolic Protection Devices Companies and Product Overview 15

5.1 Abbott Vascular Inc Company Overview 15

5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 15

5.2 AorticLab Sarl Company Overview 16

5.2.1 AorticLab Sarl Pipeline Products & Ongoing Clinical Trials Overview 16

5.3 Artio Medical Company Overview 18

5.3.1 Artio Medical Pipeline Products & Ongoing Clinical Trials Overview 18

5.4 Avantec Vascular Corp Company Overview 22

5.4.1 Avantec Vascular Corp Pipeline Products & Ongoing Clinical Trials Overview 22

5.5 Capture Vascular Inc Company Overview 23

5.5.1 Capture Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 23

5.6 Cardio-Flow Ltd. Company Overview 25

5.6.1 Cardio-Flow Ltd. Pipeline Products & Ongoing Clinical Trials Overview 25

5.7 Cardiovascular Systems Inc Company Overview 26

5.7.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.8 Emboline, Inc. Company Overview 28

5.8.1 Emboline, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28

5.9 Filterlex Medical Ltd Company Overview 31

5.9.1 Filterlex Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

5.10 Innovative Cardiovascular Solutions, LLC Company Overview 32

5.10.1 Innovative Cardiovascular Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview 32

5.11 Innovia LLC Company Overview 35

5.11.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 35

5.12 Javelin Medical Ltd Company Overview 36

5.12.1 Javelin Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

5.13 Keystone Heart Ltd Company Overview 39

5.13.1 Keystone Heart Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

5.14 Marblehead Medical LLC Company Overview 42

5.14.1 Marblehead Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 42

5.15 Medtronic Plc Company Overview 43

5.15.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 43

5.16 MIV Therapeutics Inc Company Overview 45

5.16.1 MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 45

5.17 Neurosonix Ltd. Company Overview 46

5.17.1 Neurosonix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 46

5.18 Protembis GmbH Company Overview 47

5.18.1 Protembis GmbH Pipeline Products & Ongoing Clinical Trials Overview 47

5.19 University of Minnesota Company Overview 48

5.19.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 48

5.20 University of Toledo Company Overview 49

5.20.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview 49

6 Peripheral Embolic Protection Devices- Recent Developments 50

6.1 Jun 15, 2020: MicroPort announces strategic investment and forms joint venture with Indian medical device company purple medical 50

6.2 May 15, 2020: Microport orthopedics group brings in new strategic investors 50

6.3 May 13, 2020: Truleaf Medical's successful mitral valve replacement large animals clinical trial proves the accurate deployment and long-term functioning of the implants in the heart 52

6.4 Apr 14, 2020: BioCardia announces litigation financing in the case captioned Boston Scientific 53

6.5 Mar 11, 2020: Keystone Heart secures CE Mark for cerebral embolic protection device 53

6.6 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity Officer 54

6.7 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer 55

6.8 Feb 18, 2020: Medtronic reports third quarter financial results 2020 55

6.9 Feb 11, 2020: Metactive Medical Announces Name Change to Artio Medical 58

6.10 Feb 06, 2020: AngioDynamics appoints Stephen Trowbridge Executive Vice President and Chief Financial Officer 58

6.11 Feb 05, 2020: Boston Scientific announces results for fourth quarter and full year 2019 59

6.12 Jan 28, 2020: Inari Medical appoints Cynthia Lucchese and Catherine Szyman to the company's Board of Directors 60

6.13 Jan 16, 2020: Emboline concludes enrolment for study of catheter device 61

6.14 Jan 14, 2020: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2019 62

6.15 Jan 07, 2020: AngioDynamics reports fiscal 2020 second quarter financial results 63

6.16 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe 65

6.17 Nov 25, 2019: Maggie Yuen appointed Chief Financial Officer of Penumbra 65

6.18 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 66

6.19 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 68

6.20 Nov 07, 2019: Penumbra reports third quarter 2019 financial results 70

6.21 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 70

6.22 Oct 23, 2019: Edwards Lifesciences reports third quarter results 72

6.23 Oct 22, 2019: AngioDynamics announces departure of CFO and appointment of interim CFO 75

6.24 Oct 21, 2019: Sean Salmon named executive vice president and group president of Medtronic Diabetes 76

6.25 Oct 10, 2019: CINDE announces Edwards Lifesciences invests $100 million to expand its operations in Costa Rica 77

6.26 Oct 03, 2019: AngioDynamics reports fiscal 2020 first quarter financial results 78

7 Appendix 80

7.1 Methodology 80

7.2 About GlobalData 84

7.3 Contact Us 84

7.4 Disclaimer 84

List of Tables

Table 1: Peripheral Embolic Protection Devices – Pipeline Products by Stage of Development 7

Table 2: Peripheral Embolic Protection Devices – Pipeline Products by Segment 8

Table 3: Peripheral Embolic Protection Devices – Pipeline Products by Territory 9

Table 4: Peripheral Embolic Protection Devices – Pipeline Products by Regulatory Path 10

Table 5: Peripheral Embolic Protection Devices – Pipeline Products by Estimated Approval Date 11

Table 6: Peripheral Embolic Protection Devices – Ongoing Clinical Trials 12

Table 7: Peripheral Embolic Protection Devices Companies – Pipeline Products by Stage of Development 13

Table 8: Peripheral Embolic Protection Devices – Pipeline Products by Stage of Development 14

Table 9: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 15

Table 10: Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) – Product Status 15

Table 11: Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) – Product Description 15

Table 12: AorticLab Sarl Pipeline Products & Ongoing Clinical Trials Overview 16

Table 13: Transcatheter Antiembolic Filter – Product Status 16

Table 14: Transcatheter Antiembolic Filter – Product Description 16

Table 15: Transcatheter Debridement Device (TDD) – Product Status 17

Table 16: Transcatheter Debridement Device (TDD) – Product Description 17

Table 17: Artio Medical Pipeline Products & Ongoing Clinical Trials Overview 18

Table 18: Aneura Embolization Device – Product Status 18

Table 19: Aneura Embolization Device – Product Description 18

Table 20: Aneura Embolization Coils – Product Status 19

Table 21: Aneura Embolization Coils – Product Description 19

Table 22: Blockstent Microcatheter – Product Status 19

Table 23: Blockstent Microcatheter – Product Description 20

Table 24: Solus Flex Embolization Device – Product Status 20

Table 25: Solus Flex Embolization Device – Product Description 20

Table 26: Solus Gold Embolization Device – Product Status 21

Table 27: Solus Gold Embolization Device – Product Description 21

Table 28: Avantec Vascular Corp Pipeline Products & Ongoing Clinical Trials Overview 22

Table 29: Peripheral Embolization Device – Product Status 22

Table 30: Peripheral Embolization Device – Product Description 22

Table 31: Capture Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 23

Table 32: Megavac – BTK – Product Status 23

Table 33: Megavac – BTK – Product Description 23

Table 34: Thrombowire Clot Retractor – BTK – Product Status 24

Table 35: Thrombowire Clot Retractor – BTK – Product Description 24

Table 36: Cardio-Flow Ltd. Pipeline Products & Ongoing Clinical Trials Overview 25

Table 37: EmboPRO EPD – Product Status 25

Table 38: EmboPRO EPD – Product Description 25

Table 39: Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 26

Table 40: WIRION EPD System – LE Atherectomy – Product Status 26

Table 41: WIRION EPD System – LE Atherectomy – Product Description 27

Table 42: Emboline, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28

Table 43: Emboliner – Product Status 28

Table 44: Emboliner – Product Description 28

Table 45: Emboline, Inc. – Ongoing Clinical Trials Overview 29

Table 46: Emboliner – A Prospective, Non-randomized, Multi-center, Open-label Clinical Investigation to Assess the Safety and Technical Performance of the Emboliner Embolic Protection Catheter 30

Table 47: Filterlex Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

Table 48: CAPTIS – Product Status 31

Table 49: CAPTIS – Product Description 31

Table 50: Innovative Cardiovascular Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview 32

Table 51: EMBLOK Embolic Protection System – Product Status 32

Table 52: EMBLOK Embolic Protection System – Product Description 32

Table 53: Innovative Cardiovascular Solutions, LLC – Ongoing Clinical Trials Overview 33

Table 54: EMBLOK Embolic Protection System – European Study Evaluating the EMBLOK Cerebral Embolic Protection System During Transcatheter Aortic Valve Replacement (TAVR) 34

Table 55: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 35

Table 56: Permanently Implantable Embolic Balloon – Product Status 35

Table 57: Permanently Implantable Embolic Balloon – Product Description 35

Table 58: Javelin Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

Table 59: Vine – Product Status 36

Table 60: Vine – Product Description 36

Table 61: Javelin Medical Ltd – Ongoing Clinical Trials Overview 37

Table 62: Vine – Carotid Artery Implant for Trapping Upstream Emboli (CAPTURE 2) for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants 38

Table 63: Vine – Carotid Artery Implant for Trapping Upstream Emboli for Preventing Stroke in Atrial Fibrillation Patients 38

Table 64: Keystone Heart Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

Table 65: TriGuard 3 – Product Status 39

Table 66: TriGuard 3 – Product Description 40

Table 67: TriGuard Cerebral Protection Device – Product Status 40

Table 68: TriGuard Cerebral Protection Device – Product Description 41

Table 69: Marblehead Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 42

Table 70: FFRACAS Device – Product Status 42

Table 71: FFRACAS Device – Product Description 42

Table 72: Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 43

Table 73: SilverHawk With SpiderFX Embolic Protection Device – Product Status 43

Table 74: SilverHawk With SpiderFX Embolic Protection Device – Product Description 44

Table 75: MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 45

Table 76: Aortic Embolic Protection Device – Product Status 45

Table 77: Aortic Embolic Protection Device – Product Description 45

Table 78: Neurosonix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 46

Table 79: Protection Collar – Product Status 46

Table 80: Protection Collar – Product Description 46

Table 81: Protembis GmbH Pipeline Products & Ongoing Clinical Trials Overview 47

Table 82: ProtEmbo System – Product Status 47

Table 83: ProtEmbo System – Product Description 47

Table 84: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 48

Table 85: Embolic Protection Device – Product Status 48

Table 86: Embolic Protection Device – Product Description 48

Table 87: University of Toledo Pipeline Products & Ongoing Clinical Trials Overview 49

Table 88: Minimally Invasive Thrombectomy Device – Product Status 49

Table 89: Minimally Invasive Thrombectomy Device – Product Description 49

Table 90: Glossary 83

List of Figures

Figure 1: Peripheral Embolic Protection Devices – Pipeline Products by Stage of Development 7

Figure 2: Peripheral Embolic Protection Devices – Pipeline Products by Segment 8

Figure 3: Peripheral Embolic Protection Devices – Pipeline Products by Territory 9

Figure 4: Peripheral Embolic Protection Devices – Pipeline Products by Regulatory Path 10

Figure 5: Peripheral Embolic Protection Devices – Pipeline Products by Estimated Approval Date 11

Figure 6: Peripheral Embolic Protection Devices – Ongoing Clinical Trials 12

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports